152 related articles for article (PubMed ID: 36806887)
21. Knockdown of TRIM47 inhibits breast cancer tumorigenesis and progression through the inactivation of PI3K/Akt pathway.
Wang Y; Liu C; Xie Z; Lu H
Chem Biol Interact; 2020 Feb; 317():108960. PubMed ID: 31981573
[TBL] [Abstract][Full Text] [Related]
22. Sorafenib inhibits growth and metastasis of hepatocellular carcinoma by blocking STAT3.
Gu FM; Li QL; Gao Q; Jiang JH; Huang XY; Pan JF; Fan J; Zhou J
World J Gastroenterol; 2011 Sep; 17(34):3922-32. PubMed ID: 22025881
[TBL] [Abstract][Full Text] [Related]
23. Nobiletin inhibits viability of human renal carcinoma cells via the JAK2/STAT3 and PI3K/Akt pathway.
Xu Z; Wu D; Fu D; Tang C; Ge J; Zhang Z; Zhou W
Cell Mol Biol (Noisy-le-grand); 2020 Jul; 66(5):199-203. PubMed ID: 33040836
[TBL] [Abstract][Full Text] [Related]
24. NEDD4-induced degradative ubiquitination of phosphatidylinositol 4-phosphate 5-kinase α and its implication in breast cancer cell proliferation.
Tran MH; Seo E; Min S; Nguyen QT; Choi J; Lee UJ; Hong SS; Kang H; Mansukhani A; Jou I; Lee SY
J Cell Mol Med; 2018 Sep; 22(9):4117-4129. PubMed ID: 29851245
[TBL] [Abstract][Full Text] [Related]
25. Targeting prolyl isomerase Pin1 as a promising strategy to overcome resistance to cancer therapies.
Wu W; Xue X; Chen Y; Zheng N; Wang J
Pharmacol Res; 2022 Oct; 184():106456. PubMed ID: 36116709
[TBL] [Abstract][Full Text] [Related]
26. The PI3K/Akt signal hyperactivates Eya1 via the SUMOylation pathway.
Sun Y; Kaneko S; Li XK; Li X
Oncogene; 2015 May; 34(19):2527-37. PubMed ID: 24954506
[TBL] [Abstract][Full Text] [Related]
27. AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer.
Vasudevan KM; Barbie DA; Davies MA; Rabinovsky R; McNear CJ; Kim JJ; Hennessy BT; Tseng H; Pochanard P; Kim SY; Dunn IF; Schinzel AC; Sandy P; Hoersch S; Sheng Q; Gupta PB; Boehm JS; Reiling JH; Silver S; Lu Y; Stemke-Hale K; Dutta B; Joy C; Sahin AA; Gonzalez-Angulo AM; Lluch A; Rameh LE; Jacks T; Root DE; Lander ES; Mills GB; Hahn WC; Sellers WR; Garraway LA
Cancer Cell; 2009 Jul; 16(1):21-32. PubMed ID: 19573809
[TBL] [Abstract][Full Text] [Related]
28. 3-phosphoinositide-dependent kinase 1 controls breast tumor growth in a kinase-dependent but Akt-independent manner.
Gagliardi PA; di Blasio L; Orso F; Seano G; Sessa R; Taverna D; Bussolino F; Primo L
Neoplasia; 2012 Aug; 14(8):719-31. PubMed ID: 22952425
[TBL] [Abstract][Full Text] [Related]
29. FAM83B-mediated activation of PI3K/AKT and MAPK signaling cooperates to promote epithelial cell transformation and resistance to targeted therapies.
Cipriano R; Miskimen KL; Bryson BL; Foy CR; Bartel CA; Jackson MW
Oncotarget; 2013 May; 4(5):729-38. PubMed ID: 23676467
[TBL] [Abstract][Full Text] [Related]
30. WSTF promotes proliferation and invasion of lung cancer cells by inducing EMT via PI3K/Akt and IL-6/STAT3 signaling pathways.
Meng J; Zhang XT; Liu XL; Fan L; Li C; Sun Y; Liang XH; Wang JB; Mei QB; Zhang F; Zhang T
Cell Signal; 2016 Nov; 28(11):1673-82. PubMed ID: 27449264
[TBL] [Abstract][Full Text] [Related]
31. Ran is a potential therapeutic target for cancer cells with molecular changes associated with activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK pathways.
Yuen HF; Chan KK; Grills C; Murray JT; Platt-Higgins A; Eldin OS; O'Byrne K; Janne P; Fennell DA; Johnston PG; Rudland PS; El-Tanani M
Clin Cancer Res; 2012 Jan; 18(2):380-91. PubMed ID: 22090358
[TBL] [Abstract][Full Text] [Related]
32. Understanding the role of PIN1 in hepatocellular carcinoma.
Cheng CW; Leong KW; Tse E
World J Gastroenterol; 2016 Dec; 22(45):9921-9932. PubMed ID: 28018099
[TBL] [Abstract][Full Text] [Related]
33. Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 directly binds and stabilizes Nrf2 in breast cancer.
Saeidi S; Kim SJ; Guillen-Quispe YN; Jagadeesh ASV; Han HJ; Kim SH; Zhong X; Piao JY; Kim SJ; Jeong J; Shin YJ; Cha YJ; Lee HB; Han W; Min SH; Tian W; Kitamura H; Surh YJ
FASEB J; 2022 Jan; 36(1):e22068. PubMed ID: 34918396
[TBL] [Abstract][Full Text] [Related]
34. Eriodictyol inhibits breast carcinogenesis by targeting circ_0007503 and repressing PI3K/Akt pathway.
He J; Fu H; Li C; Deng Z; Chang H
Phytomedicine; 2022 Jul; 102():154159. PubMed ID: 35580441
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-6 inhibition of peroxisome proliferator-activated receptor alpha expression is mediated by JAK2- and PI3K-induced STAT1/3 in HepG2 hepatocyte cells.
Chew GS; Myers S; Shu-Chien AC; Muhammad TS
Mol Cell Biochem; 2014 Mar; 388(1-2):25-37. PubMed ID: 24242046
[TBL] [Abstract][Full Text] [Related]
36. Salt-inducible Kinase (SIK1) regulates HCC progression and WNT/β-catenin activation.
Qu C; He D; Lu X; Dong L; Zhu Y; Zhao Q; Jiang X; Chang P; Jiang X; Wang L; Zhang Y; Bi L; He J; Peng Y; Su J; Zhang H; Huang H; Li Y; Zhou S; Qu Y; Zhao Y; Zhang Z
J Hepatol; 2016 May; 64(5):1076-1089. PubMed ID: 26778753
[TBL] [Abstract][Full Text] [Related]
37. Targeting 3-phosphoinoside-dependent kinase-1 to inhibit insulin-like growth factor-I induced AKT and p70 S6 kinase activation in breast cancer cells.
Baxi SM; Tan W; Murphy ST; Smeal T; Yin MJ
PLoS One; 2012; 7(10):e48402. PubMed ID: 23119004
[TBL] [Abstract][Full Text] [Related]
38. Peptidyl-prolyl cis/trans isomerase Pin1 is critical for the regulation of PKB/Akt stability and activation phosphorylation.
Liao Y; Wei Y; Zhou X; Yang JY; Dai C; Chen YJ; Agarwal NK; Sarbassov D; Shi D; Yu D; Hung MC
Oncogene; 2009 Jul; 28(26):2436-45. PubMed ID: 19448664
[TBL] [Abstract][Full Text] [Related]
39. Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells.
Saxena NK; Sharma D; Ding X; Lin S; Marra F; Merlin D; Anania FA
Cancer Res; 2007 Mar; 67(6):2497-507. PubMed ID: 17363567
[TBL] [Abstract][Full Text] [Related]
40. Herpes simplex virus protein kinases US3 and UL13 modulate VP11/12 phosphorylation, virion packaging, and phosphatidylinositol 3-kinase/Akt signaling activity.
Eaton HE; Saffran HA; Wu FW; Quach K; Smiley JR
J Virol; 2014 Jul; 88(13):7379-88. PubMed ID: 24741093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
